Melphalan/HDS

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaNCT02678572DCTHPhase 3Completed2023-05-18Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.